Review Note
Last Update: 09/08/2024 08:40 PM
Current Deck: unit 3::PHARM 3::midterm::GI medications::GERD-PUD
PublishedCurrently Published Content
Text
PPI management
•Typical GERD symptoms without extraesophageal involvement:
•No major differences in efficacy between PPIs
•2022 ACG
guidelines: stratify by initial symptom presentation
•Typical GERD symptoms without extraesophageal involvement:
oA standard {{c1::8}}-week, {{c1::once-daily PPI}} trial is recommended
•For those with
BOTH extraesophageal and typical GERD symptoms:
oTrial {{c2::twice-daily PPI}} therapy for {{c2::8-12}} weeks before additional testing
•No major differences in efficacy between PPIs
oFor patients
who have not responded to one PPI, more than {{c4::1}} switch to another PPI {{c3::cannot be
supported}}
Extra
Lecture Notes
Missed Questions
Pathoma
Boards and Beyond
First Aid
Sketchy
Pixorize
Physeo
OME
Additional Resources
One by one
No published tags.
Pending Suggestions
No pending suggestions for this note.